AI assistant
Biocon Ltd. Regulatory Filings 2020
61176_rns_2020-06-05_29437d95-2db5-4a5a-a8e6-0e76efa3f811.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
Biocon Limited 20th KM Hosur Road Electronics City Bangalore 560 100, India T 91802808 2808 F 91 80 2852 3423 CIN: L24234KA1978PLC003417
Date of submission: June 5, 2020
| To | To | |
|---|---|---|
| The Secretary | The Secretary | |
| BSE Limited | National Stock Exchange of India Limited | |
| Department of Corporate Services | Corporate Communication Department | |
| Phiroze Jeejeebhoy Towers, | Exchange Plaza, Bandra Kurla Complex | |
| Dalal Street, Mumbai - 400 001 | Mumbai - 400 050 | |
| Scrip Code - 532523 | Scrip Symbol- BIOCON |
Dear Sir/Madam,
Sub: Meetings conducted with Institutional Investors/Research Analysts.
Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.
Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meetings were conducted with Institutional Investor I Research Analysts:
| Date | Name | Type of meeting | Location | |
|---|---|---|---|---|
| June 5, 2020Marshall Wace LLPDSP Merrill Lynch Limited | Platinum Investment Management Limited | lxl Teleconference | ||
| Government Investment Corporation, Singapore | lxl Teleconference | |||
| Group Teleconference | Bangalore | |||
We request you to kindly take above intimation on record.
Thanking You,
Yours faithfully,
For Biocon Limited
(j},; Mayank Verma Company Secretary and Compliance Officer